Immatics (IMTX) CFO reports 350,000 stock options holding

Rhea-AI Filing Summary

Immatics N.V. reported the initial beneficial ownership of its Chief Financial Officer, Ramanan Venkat, in a Form 3. He holds a stock option to buy 350,000 ordinary shares at an exercise price of $9.0000 per share, expiring on September 30, 2035.

These options vest 25% on the first anniversary of the grant date, October 1, 2025, with the remaining 75% vesting in 12 equal quarterly installments over the following three years. The filing shows this option position as a direct holding and does not report any open-market buying or selling activity.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ramanan Venkat

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 350,000 shares (Direct)

Footnotes (1)

1. [object Object]

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ramanan Venkat

(Last) (First) (Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN 72076

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	09/30/2035	Ordinary Shares	350,000	$9	D

Explanation of Responses:

1. These options to purchase ordinary shares of the Issuer vest 25% on the first anniversary of the grant date, October 1, 2025, then in 12 equal quarterly installments over the following three years.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Edward Sturchio, attorney-in-fact for Venkat Ramanan	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What insider position did Immatics (IMTX) disclose for its CFO?

Immatics disclosed that its CFO holds options on 350,000 ordinary shares. The Form 3 shows a stock option giving the Chief Financial Officer the right to buy 350,000 Immatics ordinary shares, establishing his initial reported derivative equity position with the company.

What is the exercise price of the Immatics (IMTX) CFO stock options?

The CFO’s stock options have a $9.0000 per share exercise price. This means he can purchase Immatics ordinary shares at $9.0000 if and when the options vest and are exercised, regardless of the market price at that time.

When do the Immatics (IMTX) CFO stock options vest?

The options vest 25% on October 1, 2025, then quarterly over three years. After the initial 25% cliff vesting on the first anniversary of the grant date, the remaining 75% vests in 12 equal quarterly installments.

When do the Immatics (IMTX) CFO stock options expire?

The CFO’s options expire on September 30, 2035. If they are not exercised by that date, the right to buy up to 350,000 ordinary shares at the $9.0000 exercise price will lapse and become worthless.

Does the Immatics (IMTX) Form 3 show the CFO buying or selling shares?

The Form 3 does not report any share purchases or sales. It records a holding of stock options as the CFO’s initial beneficial ownership, without any open-market buy or sell transactions disclosed in this particular filing.